CSF3 and bacterial urinary tract infection: Treatment with anti-TIMP1 antibody decreased the levels of plasma TIMP1 by 6.1-fold in UTI-bearing, in addition to lowering the levels of G-CSF by 2.8 fold as compared to the IgG control (Supp.